In BE patients, elevated levels of leptin and insulin resistance were associated, independently of GERD, with an increased risk of EAC, while elevated levels of high-molecular-weight APN were inversely correlated with EAC [163]. This evidence concerns the gene LEP and gastroesophageal reflux disease.